Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia
- 1 October 1980
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 29 (10), 956-964
- https://doi.org/10.1016/0026-0495(80)90039-6
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Drug management of hypercholesterolemiaAmerican Heart Journal, 1979
- Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.Circulation, 1979
- Colestipol hydrochloride in hypercholesterolemic patients—Effect on serum cholesterol and mortalityJournal of Chronic Diseases, 1978
- Diet and probucol in lowering cholesterol concentrations. Additive effects on plasma cholesterol concentrations in patients with familial type ii hyperlipoproteinemiaArchives of Internal Medicine, 1977
- A comparison of cholestyramine and nicotinic acid in the treatment of familial type II hyperlipoproteinaemia.British Journal of Clinical Pharmacology, 1977
- Clofibrate and niacin in coronary heart diseaseJAMA, 1975
- Long-term Changes of Serum Cholesterol with Cholesterol-altering Drugs in Patients with Coronary Heart DiseaseCirculation, 1974
- Probucol in the long-term treatment of hypercholesterolaemiaCurrent Medical Research and Opinion, 1973
- Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemiaJAMA, 1972
- Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemiaAtherosclerosis, 1972